62 *FREE* Articles Published on @BowtiedBiotech on X
January 14, 2025
How Venture Capital Dried Up in China: Lessons from Biotech Deal-Making | Ep. 451
January 9, 2025
Has the Obesity Race Become Too Crowded? | Ep. 544
January 7, 2025
The Growing Trend of U.S. Biopharma Collaborating with China | Ep. 542
December 31, 2024
Startup Headcount as a Proxy for Biotech Health
December 30, 2024
Challenges and Opportunities in European VC Fundraising in 2024
December 24, 2024
The Odds of Biotechs Getting Acquired: Navigating the Path to Exit
December 23, 2024
Next-Generation Approaches to Modulate Biology Using Small Molecules
December 22, 2024
A DANISH DISASTER: Untangling Novo Nordisk from Denmark’s GDP
December 17, 2024
AI in Drug Target Discovery: A Peak into Tomorrow
December 9, 2024
2024: The Year of Biotech Insane Megarounds
December 3, 2024
Predicting the Next Big Biotech M&A: Trends, Timelines, and Top Candidates
November 29, 2024
Variability in Small Molecule GLP-1 Adverse Event-Related Discontinuations
November 26, 2024
The Race to Tackle Neuroinflammation in Modern Neuroscience
November 23, 2024
Tome Bio Post Mortem: L-PGI: Expanding the Boundaries of Precision Gene Editing
November 19, 2024
Leverage and Cash Recycling in Venture Capital: Amplifying Gains
November 12, 2024
Novartis' "Glue Degrader" Drug Candidate for Sickle Cell Disease Shows Promise
November 5, 2024
Venture Capital Strategy: Good vs. Great
November 4, 2024
Biotech Sector Strategies for Trading post-2024 Election Implications
November 2, 2024
Trump vs. Harris: Impacts on Biotech Under the 2024 US Presidential Election
October 29, 2024
Cash Runway Crisis and Reverse Mergers: The Growing Landscape of Financial Zombie Biotechs
October 15, 2024
How Do Venture Capitalists Make Decisions
October 8, 2024
The Venture Mirage: Why Surviving Isn’t Thriving in Startup Land
October 1, 2024
Rewiring the Rules of Biology: The Expanding Landscape of Inheritance and Translation
September 24, 2024
CAR-T vs Bispecifics: A Comparative Analysis
September 21, 2024
September 16, 2024
Why PD-(L)1 x VEGF Works: A Mechanistic Perspective
September 11, 2024
Trump vs. Harris: Impact on Biotech
September 8, 2024
Biopharma Job Openings: Top Companies Hiring Now
September 4, 2024
Biological Science Drives The Dawn of a New Space Age
August 31, 2024
Emerging Beyond GLP-1 Data from the Obesity Space
August 24, 2024
Rules for Investing in Platform Biotech Companies
August 21, 2024
The Rising Trend in Venture Capital of Capital Call Activity: An Indicator of Increasing Deal Flow
August 17, 2024
Inflation, Salaries, and the Startup Ecosystem: A Complex Interplay
August 4, 2024
Japan Stock Market Crash: Implications for the Biotech Sector
July 31, 2024
Next-Generation ADC (Antibody-Drug Conjugate) Development
July 24, 2024
Unleashing the Tumor-Fighting Potential of B Cells - Pan-Cancer Potential?
July 23, 2024
New Liquidity Option Emerges for Old VC Funds
July 20, 2024
Sleep & Risk of Chronic Disease
July 10, 2024
Dear Diary: Getting Biotech Financing Done in 2024
July 6, 2024
European Venture Capital Outperforms US Counterparts
July 3, 2024
The Post-COVID Era of Biotech Investing: Trends and Insights from Private Biotech Deal Making
July 1, 2024
Evaluating Danuglipron's New Formulations: Addressing Key Concerns
June 29, 2024
New Genetic Obesity Targets: A Promising Frontier in Weight Management
June 27, 2024
Beam Therapeutics: Leading the Charge in Genetic Medicine
June 25, 2024
Beyond GLP-1: Mono, Double, & Triple Combos Presented at ADA
June 22, 2024
Proforma Growth Strategy > Cash Flow Growth
June 17, 2024
Patient Case Study: Kyverna CD19 CAR-T in Multiple Sclerosis
June 15, 2024
Internal vs. External R&D: Leveraging Investment and Mitigating Risks
June 13, 2024
EULAR 2024: CAR-T For Auto-Immune Disease
June 13, 2024
The Impact of High Rent Prices on Biotech Workers in Major U.S. Cities
June 11, 2024
Green Light for Donanemab: Inside the AdCom's Unanimous Vote
June 10, 2024
A Tale of Three Technologies: PASSIGE, PASTE, & Gene Writing
June 9, 2024
Prime Medicine's Groundbreaking Prime Editing Therapy: A Leap Forward in Genetic Medicine
June 1, 2024
Epoch 14 - LifeStyle Drugs Coming from Biotech?
May 30, 2024
Biotech M&A: Change is in the Air?
May 18, 2024
Biotech Business Models - Platforms vs Assets
April 25, 2024
Innovation Recycling and Thematic Investing
March 24, 2024
How R&D Tax Incentives are Fueling Biotech Innovation in Australia
March 22, 2024
Researchers Advocate for Large-Scale RNome Project to Unlock the Power of RNA | Science
March 22, 2024
Scientists Uncover 'Backtracking': A New Mechanism for Genes Control in Cells
March 7, 2024
Hacking Biotech: Capital Allocation, Recycling, and Liquidation Preferences
March 7, 2024
